• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唾液样本中 SARS-CoV-2 特异性抗体的检测。

Detection of SARS-CoV-2 Specific Antibodies in Saliva Samples.

机构信息

Institute of Hepatology, National Clinical Research Center for Infectious Disease, The Third People's Hospital of Shenzhen, The Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, China.

Clinical Laboratory, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.

出版信息

Front Immunol. 2022 Jul 8;13:880154. doi: 10.3389/fimmu.2022.880154. eCollection 2022.

DOI:10.3389/fimmu.2022.880154
PMID:35898491
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9309249/
Abstract

Molecular assays on nasopharyngeal swabs act as a confirmatory test in coronavirus disease (COVID-19) diagnosis. However, the technical requirements of nasopharyngeal sampling and molecular assays limit the testing capabilities. Recent studies suggest the use of saliva for the COVID-19 diagnostic test. In this study, 44 patients diagnosed with COVID-19 in The Third People's Hospital of Shenzhen were enrolled. Saliva and serum specimens were obtained at different time points and the immunoglobulins against SARS-CoV-2 were measured. The results showed that saliva IgA presented a higher COI value than IgG and IgM. In matched saliva and serum samples, all saliva samples presented lower IgG levels than serum samples, and only one saliva sample presented a higher IgM level. The conversion rates of saliva IgA and the detection of viral nucleic acids were analyzed in the first and second weeks after hospitalization. The positive rates increased when combining saliva IgA and viral nucleic acid detection. In conclusion, our results provide evidence that saliva IgA could serve as a useful index for the early diagnosis of COVID-19.

摘要

对鼻咽拭子进行分子检测可作为冠状病毒病 (COVID-19) 诊断的确认试验。然而,鼻咽采样和分子检测的技术要求限制了检测能力。最近的研究表明,唾液可用于 COVID-19 的诊断检测。在这项研究中,共纳入了在深圳市第三人民医院确诊的 44 例 COVID-19 患者。在不同时间点采集唾液和血清标本,并检测针对 SARS-CoV-2 的免疫球蛋白。结果显示,唾液 IgA 的 COI 值高于 IgG 和 IgM。在配对的唾液和血清样本中,所有唾液样本的 IgG 水平均低于血清样本,只有一份唾液样本的 IgM 水平较高。分析了住院后第一周和第二周时唾液 IgA 的转化率和病毒核酸的检测情况。当结合唾液 IgA 和病毒核酸检测时,阳性率增加。总之,我们的结果为唾液 IgA 可作为 COVID-19 早期诊断的有用指标提供了证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa84/9309249/06b9a16ef3d2/fimmu-13-880154-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa84/9309249/e42308ebc62f/fimmu-13-880154-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa84/9309249/06b9a16ef3d2/fimmu-13-880154-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa84/9309249/e42308ebc62f/fimmu-13-880154-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa84/9309249/06b9a16ef3d2/fimmu-13-880154-g002.jpg

相似文献

1
Detection of SARS-CoV-2 Specific Antibodies in Saliva Samples.唾液样本中 SARS-CoV-2 特异性抗体的检测。
Front Immunol. 2022 Jul 8;13:880154. doi: 10.3389/fimmu.2022.880154. eCollection 2022.
2
Closing the serological gap in the diagnostic testing for COVID-19: The value of anti-SARS-CoV-2 IgA antibodies.弥补 COVID-19 诊断检测中的血清学差距:抗 SARS-CoV-2 IgA 抗体的价值。
J Med Virol. 2021 Mar;93(3):1436-1442. doi: 10.1002/jmv.26422. Epub 2020 Aug 21.
3
Multiplex Antibody Analysis of IgM, IgA and IgG to SARS-CoV-2 in Saliva and Serum From Infected Children and Their Close Contacts.对感染儿童及其密切接触者唾液和血清中针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的IgM、IgA和IgG进行多重抗体分析。
Front Immunol. 2022 Jan 27;13:751705. doi: 10.3389/fimmu.2022.751705. eCollection 2022.
4
Diagnostic performance of four SARS-CoV-2 antibody assays in patients with COVID-19 or with bacterial and non-SARS-CoV-2 viral respiratory infections.四种 SARS-CoV-2 抗体检测试剂在 COVID-19 患者及细菌性和非 SARS-CoV-2 病毒呼吸道感染患者中的诊断性能比较。
Eur J Clin Microbiol Infect Dis. 2021 Sep;40(9):1983-1997. doi: 10.1007/s10096-021-04285-4. Epub 2021 Jun 9.
5
SARS-CoV-2 antibodies: IgA correlates with severity of disease in early COVID-19 infection.严重急性呼吸综合征冠状病毒 2 型抗体:IgA 与 COVID-19 感染早期疾病的严重程度相关。
J Med Virol. 2021 Sep;93(9):5409-5415. doi: 10.1002/jmv.27058. Epub 2021 May 12.
6
Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients.COVID-19 患者血清和唾液中针对 SARS-CoV-2 刺突抗原的抗体反应持续存在。
Sci Immunol. 2020 Oct 8;5(52). doi: 10.1126/sciimmunol.abe5511.
7
Characteristics and roles of severe acute respiratory syndrome coronavirus 2-specific antibodies in patients with different severities of coronavirus 19.新型冠状病毒 2 特异性抗体在不同严重程度新型冠状病毒肺炎患者中的特征和作用。
Clin Exp Immunol. 2020 Nov;202(2):210-219. doi: 10.1111/cei.13500. Epub 2020 Aug 7.
8
Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients.通过快速诊断免疫分析检测 COVID-19 患者的 SARS-CoV-2 特异性抗体。
Virol J. 2021 Mar 9;18(1):52. doi: 10.1186/s12985-021-01530-2.
9
Impact of SARS-CoV-2 on saliva: TNF-⍺, IL-6, IL-10, lactoferrin, lysozyme, IgG, IgA, and IgM.SARS-CoV-2 对唾液的影响:TNF-α、IL-6、IL-10、乳铁蛋白、溶菌酶、IgG、IgA 和 IgM。
J Oral Biosci. 2022 Mar;64(1):108-113. doi: 10.1016/j.job.2022.01.007. Epub 2022 Jan 25.
10
Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19.新型冠状病毒血清学检测方法在 SARS-CoV-2 感染和 COVID-19 诊断中的研究进展。
Front Public Health. 2021 Feb 18;8:620222. doi: 10.3389/fpubh.2020.620222. eCollection 2020.

引用本文的文献

1
The omicron variant of SARS-CoV-2 drove broadly increased seroprevalence in a public university setting.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的奥密克戎变异株导致一所公立大学环境中的血清阳性率普遍上升。
PLOS Glob Public Health. 2025 Jan 3;5(1):e0003893. doi: 10.1371/journal.pgph.0003893. eCollection 2025.
2
Severe acute respiratory syndrome coronavirus 2-reactive salivary antibody detection in South Carolina emergency healthcare workers, September 2019-March 2020.2019 年 9 月至 2020 年 3 月,南卡罗来纳州急诊医护人员中严重急性呼吸综合征冠状病毒 2 反应性唾液抗体的检测。
Epidemiol Infect. 2024 Sep 25;152:e102. doi: 10.1017/S0950268824000967.
3

本文引用的文献

1
Characteristics and Detection Rate of SARS-CoV-2 in Alternative Sites and Specimens Pertaining to Dental Practice: An Evidence Summary.与牙科实践相关的替代部位和样本中新型冠状病毒的特征及检出率:证据总结
J Clin Med. 2021 Mar 10;10(6):1158. doi: 10.3390/jcm10061158.
2
Diagnosis of SARS-Cov-2 Infection by RT-PCR Using Specimens Other Than Naso- and Oropharyngeal Swabs: A Systematic Review and Meta-Analysis.使用鼻咽拭子和口咽拭子以外的标本通过逆转录聚合酶链反应诊断新型冠状病毒2019感染:一项系统评价和荟萃分析。
Diagnostics (Basel). 2021 Feb 21;11(2):363. doi: 10.3390/diagnostics11020363.
3
Performance of Saliva, Oropharyngeal Swabs, and Nasal Swabs for SARS-CoV-2 Molecular Detection: a Systematic Review and Meta-analysis.
Antibody responses in blood and saliva post COVID-19 bivalent booster do not reveal an Omicron BA.4/BA.5- specific response.
接种 COVID-19 二价加强针后血液和唾液中的抗体反应并未显示出针对奥密克戎 BA.4/BA.5 的特异性反应。
Front Immunol. 2024 May 15;15:1401209. doi: 10.3389/fimmu.2024.1401209. eCollection 2024.
4
Direct enhancement of viral neutralising antibody potency by the complement system: a largely forgotten phenomenon.补体系统直接增强病毒中和抗体效力:一个被广泛遗忘的现象。
Cell Mol Life Sci. 2024 Jan 11;81(1):22. doi: 10.1007/s00018-023-05074-2.
5
SARS-CoV-2 Spike Protein-Expressing Enterococcus for Oral Vaccination: Immunogenicity and Protection.用于口服疫苗接种的表达严重急性呼吸综合征冠状病毒2刺突蛋白的肠球菌:免疫原性和保护作用
Vaccines (Basel). 2023 Nov 14;11(11):1714. doi: 10.3390/vaccines11111714.
唾液、咽拭子和鼻拭子用于 SARS-CoV-2 分子检测的性能:系统评价和荟萃分析。
J Clin Microbiol. 2021 Apr 20;59(5). doi: 10.1128/JCM.02881-20.
4
The Sensitivity and Costs of Testing for SARS-CoV-2 Infection With Saliva Versus Nasopharyngeal Swabs : A Systematic Review and Meta-analysis.用唾液与鼻咽拭子检测 SARS-CoV-2 感染的敏感性和成本:系统评价和荟萃分析。
Ann Intern Med. 2021 Apr;174(4):501-510. doi: 10.7326/M20-6569. Epub 2021 Jan 12.
5
Efficacy of commercial mouth-rinses on SARS-CoV-2 viral load in saliva: randomized control trial in Singapore.商用漱口水对唾液中SARS-CoV-2病毒载量的疗效:新加坡的随机对照试验
Infection. 2021 Apr;49(2):305-311. doi: 10.1007/s15010-020-01563-9. Epub 2020 Dec 14.
6
Saliva for diagnosis of SARS-CoV-2: First report from India.唾液用于 SARS-CoV-2 的诊断:来自印度的首次报告。
J Med Virol. 2021 Apr;93(4):2529-2533. doi: 10.1002/jmv.26719. Epub 2020 Dec 23.
7
Significance of IgA antibody testing for early detection of SARS-CoV-2.IgA抗体检测对严重急性呼吸综合征冠状病毒2型早期检测的意义
J Med Virol. 2021 Apr;93(4):1888-1889. doi: 10.1002/jmv.26703. Epub 2020 Dec 17.
8
IgA dominates the early neutralizing antibody response to SARS-CoV-2.IgA 在针对 SARS-CoV-2 的早期中和抗体反应中占主导地位。
Sci Transl Med. 2021 Jan 20;13(577). doi: 10.1126/scitranslmed.abd2223. Epub 2020 Dec 7.
9
Detection of SARS-CoV-2 in saliva: implications for specimen transport and storage.唾液中 SARS-CoV-2 的检测:对标本运输和储存的影响。
J Med Microbiol. 2021 Feb;70(2). doi: 10.1099/jmm.0.001285.
10
Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19.新冠病毒感染轻症与重症患者的系统性及黏膜性抗体对 SARS-CoV-2 的应答特征。
J Allergy Clin Immunol. 2021 Feb;147(2):545-557.e9. doi: 10.1016/j.jaci.2020.10.040. Epub 2020 Nov 20.